Oral Cognitive Composition for Multi-Pathway Memory Support
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for enhancing memory and cognitive performance, such as pharmaceutical interventions and cognitive training, have limitations in effectively improving memory, focus, and attention through specific pathways like glutamate receptor signaling and BDNF synthesis.
Innovation Solution
Compositions comprising agents that increase glutamate concentration, dopamine production, and BDNF levels, along with NMDA and AMPA receptor modulators and acetylcholinesterase inhibitors, are formulated to enhance memory and focus.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmaceutical or nutraceutical interventions are used to enhance cognitive performance, then memory and focus may be improved, but the effectiveness through specific pathways like glutamate receptor signaling and BDNF synthesis remains limited
Solution Approach 1:
The composition is segmented into multiple distinct active ingredients, each targeting specific cognitive pathways: phosphatidylserine for membrane fluidity and receptor function, D-glutamine for glutamate synthesis, ginkgolide B for NMDA/AMPA receptor modulation, and ascorbic acid for BDNF synthesis support. This segmentation allows each component to act on its designated pathway while collectively improving overall cognitive performance through multiple mechanisms simultaneously.
2Adaptability or versatility
If a composition includes multiple agents targeting different pathways, then pathway-specific effectiveness is improved, but the composition complexity increases
Solution Approach 1:
Multiple active ingredients targeting different cognitive pathways are merged into a single integrated composition. The formulation combines phosphatidylserine, D-glutamine, ginkgolide B, and ascorbic acid in specific proportions, allowing simultaneous action on membrane fluidity, glutamate signaling, receptor modulation, and BDNF synthesis. This merging approach simplifies administration while maintaining multi-pathway effectiveness.
Solution Approach 2:
The composition functions as a composite material where each ingredient contributes a specific functional property: phosphatidylserine provides membrane structure and receptor modulation, D-glutamine supplies precursor for glutamate synthesis, ginkgolide B adds NMDA/AMPA receptor modulation, and ascorbic acid supports BDNF production. The composite nature allows synergistic effects while managing complexity through defined ratios and formulations.
Data Source
AI summary
The present disclosure relates to oral compositions that include at least two agents selected from: agents that increase the concentration of glutamate; agents that increase dopamine production; agents that increase the concentration of brain-derived neurotrophic factor (BDNF); NMDA and/or AMPA receptor modulators; and acetylcholinesterase inhibitors. In son embodiments, a composition as provided herein includes D-glutamine present in an amount of about 20% to about 30% w/w of the composition; ginkgolide B present in an amount of about 0.1% to about 0.4% w/w of the composition; phosphatidylserine present in an amount of about 65% to about 80% w/w of the composition; and ascorbic acid present in an amount of about 0.5% to about 2.5% w/w of the composition. Such compositions are useful for improving memory and/or focus.